Pharming Group N.V. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 167.68 million compared to EUR 185.69 million a year ago. Net income was EUR 13.49 million compared to EUR 33.04 million a year ago.

Basic earnings per share from continuing operations was EUR 0.021 compared to EUR 0.051 a year ago. Diluted earnings per share from continuing operations was EUR 0.019 compared to EUR 0.048 a year ago.